Vanguard Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Vanguard Capital Management's VRTX Position: Q3 2026 in Review
Vanguard Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.09% in Q3 2026, buying an estimated $7.82M and bringing the position to 16,595,978 shares worth $8.68B. The position accounts for 0.18% of the portfolio, ranked #86.
Vanguard Capital Management first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,625 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Vanguard Capital Management held 16,595,978 shares of Vertex Pharmaceuticals worth $8.68B as of Q3 2026.
- Vanguard Capital Management bought 15,265 Vertex Pharmaceuticals shares in Q3 2026, an estimated $7.82M.
- Vertex Pharmaceuticals made up 0.18% of Vanguard Capital Management's portfolio in Q3 2026, its #86 holding.
- Vanguard Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 1,625 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.